HSS MEDICAL LEADERSHIP
Benjamin M. Rosen Chair in Immunology and In ammation Research Mary K. Crow, MD Dr. Mary Crow, Physician-in-Chief and Chair of the Division of Rheumatology, studies the immunologic basis of systemic autoimmune diseases with support from the Benjamin M. Rosen Chair in Immunology and In ammation Research. Her research is focused on patients with systemic lupus erythematosus with the goal of identifying molecular and cellular mechanisms that might be therapeutically targeted to control disease activity and prevent disease ares.
Joseph P. Routh Professor of Rheumatic Diseases in Medicine The Joseph P. Routh Professorship of Rheumatic Diseases in Medicine supports Dr. Mary Crow (pictured above), the Hospital’s Physician-in-Chief and Chair of the Division of Rheumatology. She is Past President of the American College of Rheumatology and currently serves as Director of the Autoimmunity and In ammation Research Program at HSS. The Routh Professorship serves to honor and support the Physician-in-Chief’s leadership role in guiding the Hospital’s Department of Medicine faculty to achieve the highest level of academic accomplishment and innovative patient care.
Richard L. Menschel Chair and Chief Scientiÿc O cer Lionel B. Ivashkiv, MD Dr. Lionel Ivashkiv is Chief Scientiÿc O cer and a premier scientist in in ammatory and musculoskeletal diseases. Dr. Ivashkiv oversees the Hospital’s clinical, translational, and basic research programs, which encompass over 300 scientists and sta‡ working to identify the causes of, and new treatments for, musculoskeletal and autoimmune diseases. As CSO, Dr. Ivashkiv is working to develop and execute strategic plans to build and enhance the position of HSS as an international leader in orthopedic and rheumatic disease research. Under his leadership, long-term research goals include expanding translational research; building multidisciplinary teams to answer key clinical questions; enhancing clinical research; and broadening the scope and impact of basic science on musculoskeletal disorders, with a focus on regenerative medicine, genomics, new treatments, and precision medicine.
David H. Koch Chair for Arthritis and Tissue Degeneration Research Dr. Lionel Ivashkiv (pictured above) is Chief Scientiÿc O cer and a leading authority in the ÿeld of cytokine research. Cytokines are proteins that play a critical role in in ammation, arthritis, and many rheumatic and orthopedic conditions. Dr. Ivashkiv’s laboratory has identiÿed potential new therapeutic targets for inhibiting the chronic in ammation and bone destruction that are characteristic of many musculoskeletal diseases, including rheumatoid arthritis and orthopedic implant loosening/osteolysis. Dr. Ivashkiv has also described new therapeutic approaches for combating lupus. As the Director of the David Z. Rosensweig Genomics Research Center at HSS, Dr. Ivashkiv is leading the application of advanced genomic technologies for patients with musculoskeletal diseases, in order to discover molecular pathways that can be targeted therapeutically. This precision medicine approach promises to provide personalized treatments for patients with orthopedic and rheumatologic conditions. 2 | Advancing the Frontiers of Medicine